Thiopurines and anti-TNF therapy appear to be associated with a small but significantly increased risk of lymphoma in patients with IBD. A French study identified 336 lymphoma cases in more than 189,000 patients with IBD followed for a median of seven years. Patients not exposed to either drug had an incidence rate of lymphoma of ...
Lymphoma (relative) risk increases with IBD drugs
By Mardi Chapman
9 Nov 2017